Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Action Pharma presents data from phase II trial of AP-214

Nov. 29, 2011

Interim data presented from the first-in-human trial of MABp1 in advanced tumors

Nov. 29, 2011

Highly selective mGlu4 receptor positive allosteric modulator discovered

Nov. 29, 2011

Preclinical results reported for LEE-011 in human liposarcoma

Nov. 28, 2011

Angiogenesis inhibitor may enhance effects of therapy with oncolytic virus

Nov. 28, 2011

Japanese researchers identify new biomarker for diagnosis/monitoring of RA

Nov. 28, 2011

Mibefradil dihydrochloride given with temozolomide in murine glioma model

Nov. 28, 2011

In vitro and clinical data presented on Vitae Pharmaceuticals' renin inhibitor

Nov. 28, 2011

Multicomponent natural medication may target multiple Alzheimer's disease pathways

Nov. 25, 2011

Phase III study investigates phosphate-lowering effects of SBR-759

Nov. 25, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...